发达国家5岁以下儿童轮状病毒疾病及医疗资源使用:系统综述与荟萃分析
该系统综述纳入21个国家74项研究,估算未常规接种轮状病毒疫苗的高度发达国家5岁以下儿童轮状病毒胃肠炎的医疗使用率和急性胃肠炎中轮状病毒占比。每10万人年发病率:初级保健就诊2484、急诊就诊1890、住院500、院内感染34、死亡0.04。轮状病毒占住院急性胃肠炎41%,占死亡12%,死亡率低但医疗负担重,异质性高。
要点
- 未常规接种疫苗的发达国家5岁以下儿童轮状病毒胃肠炎住院率为500/10万人年。
- 轮状病毒占5岁以下儿童急性胃肠炎住院的41%,占急诊就诊的32%。
- 轮状病毒相关死亡率为0.04/10万人年,疾病负担以就诊和住院为主。
核心结论
- 在未常规接种轮状病毒疫苗的高度发达国家,5岁以下儿童轮状病毒感染导致大量医疗就诊和住院,但死亡率低。
- 本研究的医疗使用估计可用于建模轮状病毒疫苗在高度发达国家的成本效果。
研究设计与样本
- 系统综述与随机效应荟萃分析,检索MEDLINE和Embase从2000年1月1日至2018年12月17日的文献。
- 纳入74项来自21个国家的实验室确诊轮状病毒感染研究,对象为5岁以下儿童,研究地点为未常规接种轮状病毒疫苗的高度发达国家。
主要发现
- 每10万人年轮状病毒胃肠炎发病率:初级保健就诊2484(95%CI 697-5366),急诊就诊1890(95%CI 1597-2207),住院500(95%CI 422-584),院内感染34(95%CI 20-51),死亡0.04(95%CI 0.02-0.07)。
- 轮状病毒占急性胃肠炎的比例:初级保健就诊21%(95%CI 16-26%),急诊就诊32%(95%CI 25-38%),住院41%(95%CI 36-47%),院内感染29%(95%CI 25-34%),死亡12%(95%CI 8-18%)。
- 多数模型异质性高(I2 > 90%),结果在国家间和国家内差异大。
临床怎么用
- 可为高度发达国家评估轮状病毒疫苗成本效果提供医疗使用参数。
- 提示在未常规接种疫苗的发达国家,轮状病毒相关住院和急诊负担仍显著。
局限性
- 仅纳入实验室确诊轮状病毒感染的研究,可能低估实际负担。
- 多数模型异质性高(I2 > 90%),结果国家间差异大。
- 仅纳入未常规接种轮状病毒疫苗的高度发达国家,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rotavirus (RV) infection is the leading cause of diarrhoea-associated morbidity and mortality globally among children under 5 years of age. RV vaccination is available, but has not been implemented in many national immunisation plans, especially in highly developed countries. This systematic review aimed to estimate the prevalence and incidence of health care use for RV gastroenteritis (RVGE) among children aged under 5 years in highly developed countries without routine RV vaccination. METHODS: We searched MEDLINE and Embase databases from January 1st 2000 to December 17th 2018 for publications reporting on incidence or prevalence of RVGE-related health care use in children below 5 years of age: primary care and emergency department (ED) visits, hospitalisations, nosocomial infections and deaths. We included only studies with laboratory-confirmed RV infection, undertaken in highly developed countries with no RV routine vaccination plans. We used random effects meta-analysis to generate summary estimates with 95% confidence intervals (CI) and prediction intervals. RESULTS: We screened 4033 abstracts and included 74 studies from 21 countries. Average incidence rates of RVGE per 100 000 person-years were: 2484 (95% CI 697-5366) primary care visits, 1890 (1597-2207) ED visits, 500 (422-584) hospitalisations, 34 (20-51) nosocomial infections and 0.04 (0.02-0.07) deaths. Average proportions of cases of acute gastroenteritis caused by RV were: 21% (95% CI 16-26%) for primary care visits; 32% (25-38%) for ED visits; 41% (36-47%) for hospitalisations, 29% (25-34%) for nosocomial infections and 12% (8-18%) for deaths. Results varied widely between and within countries, and heterogeneity was high (I2 > 90%) in most models. CONCLUSION: RV in children under 5 years causes many healthcare visits and hospitalisations, with low mortality, in highly developed countries without routine RV vaccination. The health care use estimates for RVGE obtained by this study can be used to model RV vaccine cost-effectiveness in highly developed countries.
引用
- Ardura-Garcia C, Kreis C, Rakic M, et al. Rotavirus disease and health care utilisation among children under 5 years of age in highly developed countries: A systematic review and meta-analysis. Vaccine. 2021. PMID: 33934916. doi:10.1016/j.vaccine.2021.04.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。